Correlates of Opioid Use Among Ontario Long-Term Care Residents and Variation by Pain Frequency and Intensity: A Cross-sectional Analysis.
Journal
Drugs & aging
ISSN: 1179-1969
Titre abrégé: Drugs Aging
Pays: New Zealand
ID NLM: 9102074
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
accepted:
26
07
2022
pubmed:
18
8
2022
medline:
14
10
2022
entrez:
17
8
2022
Statut:
ppublish
Résumé
Chronic non-cancer pain is common among older residents of long-term care (LTC) homes and often poorly recognized and treated. With heightened concerns regarding opioid prescribing in recent years, it is important to examine the current prevalence of opioid use and its association with resident characteristics to help identify those potentially at risk of medication harms as well as suboptimal pain management. The aims were to estimate the prevalence and correlates of opioid use among non-palliative LTC residents and explore variation in opioid prevalence and correlates across strata defined by pain frequency and intensity. We conducted a population-based cross-sectional study of all older (aged > 65 years) LTC residents (excluding those with cancer or receiving palliative care) in Ontario, Canada during 2018-2019. Health administrative databases were linked with standardized clinical assessment data to ascertain residents' health and pain characteristics and their opioid and other medication use. Modified Poisson regression models estimated unadjusted and adjusted associations between residents' characteristics and opioid use, overall and across strata capturing pain frequency and intensity. Among 75,020 eligible residents (mean age 85.1 years; 70% female), the prevalence of opioid use was 18.5% and pain was 29.4%. Opioid use ranged from 12.2% for residents with no current pain to 55.7% for those with severe pain. In adjusted models, residents newly admitted to LTC (adjusted risk ratio [aRR] = 0.60, 95% confidence interval [CI] 0.57-0.62) and with moderate to severe cognitive impairment (aRR = 0.69, 95% CI 0.66-0.72) or dementia (aRR = 0.76, 95% CI 0.74-0.79) were significantly less likely to receive an opioid, whereas residents with select conditions (e.g., arthritis, aRR = 1.37, 95% CI 1.32-1.41) and concurrently using gabapentinoids (aRR = 1.80, 95% CI 1.74-1.86), benzodiazepines (aRR = 1.33, 95% CI 1.28-1.38), or antidepressants (aRR = 1.31, 95% CI 1.27-1.35) were significantly more likely to receive an opioid. The associations observed for residents newly admitted, with dementia, and concurrently using gabapentinoids, benzodiazepines, or antidepressants were largely consistent across all pain strata. Our findings describe resident sub-groups at potentially higher risk of adverse health outcomes in relation to both opioid use and non-use. LTC clinical and policy changes informed by research are required to ensure the appropriate recognition and management of non-cancer pain in this setting.
Sections du résumé
BACKGROUND
Chronic non-cancer pain is common among older residents of long-term care (LTC) homes and often poorly recognized and treated. With heightened concerns regarding opioid prescribing in recent years, it is important to examine the current prevalence of opioid use and its association with resident characteristics to help identify those potentially at risk of medication harms as well as suboptimal pain management.
OBJECTIVES
The aims were to estimate the prevalence and correlates of opioid use among non-palliative LTC residents and explore variation in opioid prevalence and correlates across strata defined by pain frequency and intensity.
METHODS
We conducted a population-based cross-sectional study of all older (aged > 65 years) LTC residents (excluding those with cancer or receiving palliative care) in Ontario, Canada during 2018-2019. Health administrative databases were linked with standardized clinical assessment data to ascertain residents' health and pain characteristics and their opioid and other medication use. Modified Poisson regression models estimated unadjusted and adjusted associations between residents' characteristics and opioid use, overall and across strata capturing pain frequency and intensity.
RESULTS
Among 75,020 eligible residents (mean age 85.1 years; 70% female), the prevalence of opioid use was 18.5% and pain was 29.4%. Opioid use ranged from 12.2% for residents with no current pain to 55.7% for those with severe pain. In adjusted models, residents newly admitted to LTC (adjusted risk ratio [aRR] = 0.60, 95% confidence interval [CI] 0.57-0.62) and with moderate to severe cognitive impairment (aRR = 0.69, 95% CI 0.66-0.72) or dementia (aRR = 0.76, 95% CI 0.74-0.79) were significantly less likely to receive an opioid, whereas residents with select conditions (e.g., arthritis, aRR = 1.37, 95% CI 1.32-1.41) and concurrently using gabapentinoids (aRR = 1.80, 95% CI 1.74-1.86), benzodiazepines (aRR = 1.33, 95% CI 1.28-1.38), or antidepressants (aRR = 1.31, 95% CI 1.27-1.35) were significantly more likely to receive an opioid. The associations observed for residents newly admitted, with dementia, and concurrently using gabapentinoids, benzodiazepines, or antidepressants were largely consistent across all pain strata.
CONCLUSIONS
Our findings describe resident sub-groups at potentially higher risk of adverse health outcomes in relation to both opioid use and non-use. LTC clinical and policy changes informed by research are required to ensure the appropriate recognition and management of non-cancer pain in this setting.
Identifiants
pubmed: 35976489
doi: 10.1007/s40266-022-00972-9
pii: 10.1007/s40266-022-00972-9
pmc: PMC9381389
doi:
Substances chimiques
Analgesics, Opioid
0
Benzodiazepines
12794-10-4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
811-827Subventions
Organisme : CIHR
ID : MOP-136854
Pays : Canada
Organisme : CIHR
ID : PJT 168914
Pays : Canada
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Références
Lapane KL, Hume AL, Morrison RA, Jesdale BM. Prescription analgesia and adjuvant use by pain severity at admission among nursing home residents with non-malignant pain. Eur J Clin Pharmacol. 2020;76(7):1021–8.
pubmed: 32363421
pmcid: 7306024
doi: 10.1007/s00228-020-02878-0
Iaboni A, Campitelli MA, Bronskill SE, Diong C, Kumar M, Maclagan LC, Gomes T, Tadrous M, Maxwell CJ. Time trends in opioid prescribing among Ontario long-term care residents: a repeated cross-sectional study. CMAJ Open. 2019;7(3):E582–98.
pubmed: 31551235
pmcid: 6759016
doi: 10.9778/cmajo.20190052
Hunnicutt JN, Chrysanthopoulou SA, Ulbricht CM, Hume AL, Tjia J, Lapane KL. Prevalence of long-term opioid use in long-stay nursing home residents. J Am Geriatr Soc. 2018;66(1):48–55.
pubmed: 28940193
doi: 10.1111/jgs.15080
Maclagan LC, Maxwell CJ, Gandhi S, Guan J, Bell CM, Hogan DB, Daneman N, Gill SS, Morris AM, Jeffs L, Campitelli MA, Seitz D, Bronskill SE. Frailty and potentially inappropriate medication use at nursing home transition. J Am Geriatr Soc. 2017;65(10):2205–12.
pubmed: 28752589
doi: 10.1111/jgs.15016
Al-Qurain AA, Gebremichael LG, Khan MS, Williams DB, Mackenzie L, Phillips C, Russell P, Roberts MS, Wiese MD. Opioid prescribing and risk of drug-opioid interactions in older discharged patients with polypharmacy in Australia. Int J Clin Pharm. 2021;43(2):365–74.
pubmed: 33206289
doi: 10.1007/s11096-020-01191-1
Jassal M, Egan G, Dahri K. Opioid prescribing in the elderly: a systematic review. J Pharm Technol. 2020;36(1):28–40.
pubmed: 34752514
doi: 10.1177/8755122519867975
The 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–694.
Dube CE, Morrison RA, Mack DS, Jesdale BM, Nunes AP, Liu SH, Lapane KL. Prevalence of pain on admission by level of cognitive impairment in nursing homes. J Pain Res. 2020;13:2663–72.
pubmed: 33116808
pmcid: 7586014
doi: 10.2147/JPR.S270689
Hunnicutt JN, Ulbricht CM, Tjia J, Lapane KL. Pain and pharmacologic pain management in long-stay nursing home residents. Pain. 2017;158(6):1091–9.
pubmed: 28267065
pmcid: 5435509
doi: 10.1097/j.pain.0000000000000887
Hunnicutt JN, Hume AL, Ulbricht CM, Tjia J, Lapane KL. Long-acting opioid initiation in US nursing homes. Pharmacoepidemiol Drug Saf. 2019;28(1):31–8.
pubmed: 29869441
doi: 10.1002/pds.4568
Lapane KL, Quilliam BJ, Chow W, Kim M. The association between pain and measures of well-being among nursing home residents. J Am Med Dir Assoc. 2012;13(4):344–9.
pubmed: 21450246
doi: 10.1016/j.jamda.2011.01.007
Abdulla A, Adams N, Bone M, Elliott AM, Gaffin J, Jones D, Knaggs R, Martin D, Sampson L, Schofield P; British Geriatric Society. Guidance on the management of pain in older people. Age Ageing. 2013;42(Suppl 1):i1–57.
Edelman LS, Hemmert R. Opioid use in long-term care: guidelines and policy recommendations. J Gerontol Nurs. 2019;45(9):5–10.
pubmed: 31437286
doi: 10.3928/00989134-20190813-02
Oscanoa TJ, Lizaraso F, Carvajal A. Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis. Eur J Clin Pharmacol. 2017;73(6):759–70.
pubmed: 28251277
doi: 10.1007/s00228-017-2225-3
Vranken MJM, Schutjens MDB, Mantel-Teeuwisse AK. The double opioid crisis: a call for balance. Pharmacoepidemiol Drug Saf. 2019;28(1):1–3.
pubmed: 30656799
pmcid: 6590408
doi: 10.1002/pds.4720
Helvik AS, Bergh S, Benth JS, Selbaek G, Husebo BS, Tevik K. Pain in nursing home residents with dementia and its association to quality of life. Aging Ment Health. 2021;1–11: Online ahead of print. https://doi.org/10.1080/13607863.2021.1947968
Herr K, Arnstein P. The opioid epidemic and persistent pain management in older adults. J Gerontol Nurs. 2016;42(12):3–4.
pubmed: 27898127
doi: 10.3928/00989134-20161110-01
Achterberg WP, Erdal A, Husebo BS, Kunz M, Lautenbacher S. Are chronic pain patients with dementia being undermedicated? J Pain Res. 2021;14:431–9.
pubmed: 33623425
pmcid: 7894836
doi: 10.2147/JPR.S239321
La Frenais F, Vickerstaff V, Cooper C, Livingston G, Stone P, Sampson EL. Factors influencing prescription and administration of analgesic medication: a longitudinal study of people with dementia living in care homes. Int J Geriatr Psychiatry. 2021;36(9):1354–61.
pubmed: 33719098
doi: 10.1002/gps.5526
Mehta HB, Kuo YF, Raji M, Li S, Westra J, Goodwin JS. Time trends in opioid use by dementia severity in long-term care nursing home residents. J Am Med Dir Assoc. 2021;22(1):124–31.
pubmed: 32605815
doi: 10.1016/j.jamda.2020.04.029
Nunes AP, Zhao D, Jesdale WM, Lapane KL. Multiple imputation to quantify misclassification in observational studies of the cognitively impaired: an application for pain assessment in nursing home residents. BMC Med Res Methodol. 2021;21(1):132.
pubmed: 34174838
pmcid: 8235835
doi: 10.1186/s12874-021-01327-5
Cadogan MP, Edelen MO, Lorenz KA, Jones M, Yosef J, Hascall T, Simon B, Harker JO, Ferrell B, Saliba D. The relationship of reported pain severity to perceived effect on function of nursing home residents. J Gerontol A Biol Sci Med Sci. 2008;63(9):969–73.
pubmed: 18840802
doi: 10.1093/gerona/63.9.969
Greenblatt HK, Greenblatt DJ. Use of antipsychotics for the treatment of behavioral symptoms of dementia. J Clin Pharmacol. 2016;56(9):1048–57.
pubmed: 26953213
doi: 10.1002/jcph.731
Husebo BS, Ballard C, Sandvik R, Nilsen OB, Aarsland D. Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. BMJ. 2011;343: d4065.
pubmed: 21765198
pmcid: 3137923
doi: 10.1136/bmj.d4065
Busse JW, Craigie S, Juurlink DN, Buckley DN, Wang L, Couban RJ, Agoritsas T, Aki EA, Carrasco-Labra A, Cooper L, Cull C, da Costa BR, Frank JW, Grant G, Iorio A, Persaud N, Stern S, Tugwell P, Vandvik PO, Guyatt GH. Guideline for opioid therapy and chronic noncancer pain. CMAJ. 2017;189(18):E659–66.
pubmed: 28483845
pmcid: 5422149
doi: 10.1503/cmaj.170363
Canadian Institute for Health Information, Continuing Care Reporting System (CCRS) RAI-MDS 2.0© Output Specifications Manuel, 2019-2020. Ottawa, Ont.: CIHI, 2019. https://secure.cihi.ca/estore/productFamily.htm?pf=PFC3942&lang=en&media=0
Hirdes JP, Poss JW, Caldarelli H, Fries BE, Morris JN, Teare GF, Reidel K, Jutan N. An evaluation of data quality in Canada’s Continuing Care Reporting System (CCRS): secondary analysis of Ontario data submitted between 1996–2011. BMC Med Inform Decis Mak. 2013;13:27.
pubmed: 23442258
pmcid: 3599184
doi: 10.1186/1472-6947-13-27
Campitelli MA, Bronskill SE, Maclagan LC, Harris DA, Cotton CA, Tadrous M, Gruneir A, Hogan DB, Maxwell CJ. Comparison of medication prescribing before and after the COVID-19 pandemic among nursing home residents in Ontario, Canada. JAMA Netw Open. 2021;4(8): e2118441.
pubmed: 34338794
pmcid: 8329744
doi: 10.1001/jamanetworkopen.2021.18441
Lapane KL, Quilliam BJ, Chow W, Kim MS. Pharmacologic management of non-cancer pain among nursing home residents. J Pain Symptom Manage. 2013;45(1):33–42.
pubmed: 22841409
doi: 10.1016/j.jpainsymman.2011.12.285
Fries BE, Simon SE, Morris JN, Flodstrom C, Bookstein FL. Pain in U.S. nursing homes: validating a pain scale for the minimum data set. Gerontologist. 2001;41(2):173–179.
Hartmaier SL, Sloane PD, Guess HA, Koch GG, Mitchell CM, Phillips CD. Validation of the minimum data set cognitive performance scale: agreement with the mini-mental state examination. J Gerontol A Biol Sci Med Sci. 1995;50A(2):M128–33.
doi: 10.1093/gerona/50A.2.M128
Morris JN, Fries BE, Morris SA. Scaling ADLs with the MDS. J Gerontol A Biol Sci Med Sci. 1999;54(11):M546–53.
pubmed: 10619316
doi: 10.1093/gerona/54.11.M546
Burrows AB, Morris JN, Simon SE, Hirdes JP, Phillips C. Development of a Minimum Data Set-based depression rating scale for use in nursing homes. Age Ageing. 2000;29(2):165–72.
pubmed: 10791452
doi: 10.1093/ageing/29.2.165
Perlman CM, Hirdes JP. The aggressive behavior scale: A new scale to measure aggression based on the Minimum Data Set. J Am Geriatr Soc. 2008;56(12):2298–303.
pubmed: 19093929
doi: 10.1111/j.1532-5415.2008.02048.x
Woo KY, Sears K, Almost J, Wilson R, Whitehead M, VanDenKerkhof EG. Exploration of pressure ulcer and related skin problems across the spectrum of health care settings in Ontario using administrative data. Int Wound J. 2017;14(1):24–30.
pubmed: 26584833
doi: 10.1111/iwj.12535
Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083–107.
pubmed: 19757444
pmcid: 3472075
doi: 10.1002/sim.3697
Zou G. A modifed poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6.
pubmed: 15033648
doi: 10.1093/aje/kwh090
Zou GY, Donner A. Extension of the modifed poisson regression model to prospective studies with correlated binary data. Stat Methods Med Res. 2013;22(6):661–70.
pubmed: 22072596
doi: 10.1177/0962280211427759
Roitto HM, Kautiainen H, Aalto UL, Öhman H, Laurila J, Pitkälä KH. Fouteen-year trends in the use of psychotropic medications, opioids and other sedatives among institutionalized older people in Helsinki, Finland. J Am Med Dir Assoc. 2019;20(3):305–11.
pubmed: 30824218
doi: 10.1016/j.jamda.2018.12.022
Jensen-Dahm C, Zakarias JK, Gasse C, Waldemar G. Geographical variation in opioid use in elderly patients with dementia: a nationwide study. J Alzheimers Dis. 2019;70(4):1209–16.
pubmed: 31322575
pmcid: 6839457
doi: 10.3233/JAD-190413
Gilmore-Bykovskyi AL, Block L, Hovanes M, Mirr J, Kolanowski A. Analgesic use patterns among patients with dementia during transitions from hospitals to skilled nursing facilities. Res Gerontol Nurs. 2019;12(2):61–9.
pubmed: 30703217
pmcid: 6472900
doi: 10.3928/19404921-20190122-01
Lapane KL, Dubé C, Hume AL, Tjia J, Jesdale BM, Pawasauskas J, Khodyakov D. Priority-setting to address the geriatric pharmacoparadox for pain management: a nursing home stakeholder delphi study. Drugs Aging. 2021;38(4):327–40.
pubmed: 33624228
pmcid: 8127621
doi: 10.1007/s40266-021-00836-8
Karnik V, Farcy N, Zamorano C, Bruno V. Current status of pain management in Parkinson’s disease. Can J Neurol Sci. 2020;47(3):336–43.
pubmed: 31928559
doi: 10.1017/cjn.2020.13
Mylius V, Möller JC, Bohlhalter S, de Andrade DC, Lloret SP. Diagnosis and management of pain in Parkinson’s disease: a new approach. Drugs Aging. 2021;38(7):559–77.
pubmed: 34224103
doi: 10.1007/s40266-021-00867-1
Qureshi AR, Rana AQ, Malik SH, Rizvi SFH, Akhter S, Vannabouathong C, Sarfraz Z, Rana R. Comprehensive examination of therapies for pain in Parkinson’s disease: a systematic review and meta-analysis. Neuroepidemiology. 2018;51(3–4):190–206.
pubmed: 30153669
doi: 10.1159/000492221
Saraiva MD, Suzuki GS, Lin SM, de Andrade DC, Jacob-Filho W, Suemoto CK. Persistent pain in a risk factor for frailty: a systematic review and meta-analysis from prospective longitudinal studies. Age Ageing. 2018;47(6):785–93.
pubmed: 30052700
doi: 10.1093/ageing/afy104
Hogan DB, Maxwell CJ. Frailty and unintended risks of medications. Curr Epidemiol Rep [Epidemiology of Aging Section] 2020; https://doi.org/10.1007/s40471-020-00226-5
Woodford HJ, Fisher J. New horizons in deprescribing for older people. Age Ageing. 2019;48(6):768–75.
pubmed: 31595290
doi: 10.1093/ageing/afz109
Ng R, Lane N, Tanuseputro P, Mojaverian N, Talarico R, Wodchis WP, Bronskill SE, Hsu AT. Increasing complexity of new nursing home residents in Ontario, Canada: a serial cross-sectional study. J Am Geriatr Soc. 2020;68(6):1293–300.
pubmed: 32119121
doi: 10.1111/jgs.16394
Cadogan MP, Schnelle JF, Yamamoto-Mitani N, Cabrera G, Simmons SF. A minimum data set prevalence of pain quality indicator: is it accurate and does it reflect differences in care processes? J Gerontol A Biol Sci Med Sci. 2004;59(3):281–5.
pubmed: 15031314
doi: 10.1093/gerona/59.3.M281
Cohen-Mansfield J. The adequacy of the minimum data set assessment of pain in cognitively impaired nursing home residents. J Pain Symptom Manage. 2004;27(4):343–51.
pubmed: 15050662
doi: 10.1016/j.jpainsymman.2004.01.001
Fisher SE, Burgio LD, Thorn BE, Allen-Burge R, Gerstle J, Roth DL, Allen SJ. Pain assessment and management in cognitively impaired nursing home residents: association of certified nursing assistant pain report, Minimum Data Set pain report, and analgesic medication use. J Am Geriatr Soc. 2002;50(1):152–6.
pubmed: 12028260
doi: 10.1046/j.1532-5415.2002.50021.x
Wu N, Miller SC, Lapane K, Roy J, Mor V. The quality of the quality indicator of pain derived from the minimum data set. Health Serv Res. 2005;40(4):1197–216.
pubmed: 16033500
pmcid: 1361186
doi: 10.1111/j.1475-6773.2005.00400.x
Bronskill SE, Campitelli MA, Iaboni A, Herrmann N, Guan J, Maclagan LC, Watt J, Rochon PA, Morris AM, Jeffs L, Bell CM, Maxwell CJ. Low-dose trazodone, benzodiazepines, and fall-related injuries in nursing homes: a matched-cohort study. J Am Geriatr Soc. 2018;66(10):1963–71.
pubmed: 30247773
doi: 10.1111/jgs.15519
Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson JM, van den Brink W. Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case–control study. PLoS Med. 2017;14(10): e1002396.
pubmed: 28972983
pmcid: 5626029
doi: 10.1371/journal.pmed.1002396
Gomes T, Greaves S, van den Brink W, Antoniou T, Mamdani MM, Paterson JM, Martins D. Juurlink DN Pregabalin and the risk for opioid-related death: a nested case–control study. Ann Intern Med. 2018;169(10):732–4.
pubmed: 30140853
doi: 10.7326/M18-1136
Macri JC, Iaboni A, Kirkham JG, Maxwell C, Gill SS, Vasudev A, Whitehead M, Seitz DP. Association between antidepressants and fall-related injuries among long-term care residents. Am J Geriatr Psychiatry. 2017;25(12):1326–36.
pubmed: 28943234
doi: 10.1016/j.jagp.2017.08.014
Mbrah AK, Nunes AP, Hume AL, Zhao D, Jesdale BM, Bova C, Lapane KL. Prevalence and treatment of neuropathic pain diagnoses among U.S. nursing home residents. Pain. 2021. https://doi.org/10.1097/j.pain.0000000000002525 (Online ahead of print)
Zhao D, Shridharmurthy D, Alcusky MJ, Yuan Y, Nunes AP, Hume AL, Baek J, Lapane KL. The prevalence and factors associated with antiepileptic drug use in US nursing home residents. Drugs Aging. 2020;37(2):137–45.
pubmed: 31845208
pmcid: 8098429
doi: 10.1007/s40266-019-00732-2
Rajkumar AP, Ballard C, Fossey J, Orrell M, Moniz-Cook E, Woods RT, Murray J, Whitaker R, Stafford J, Knapp M, Romeo R, Woodward-Carlton B, Khan Z, Testad I, Corbett A. Epidemiology of pain in people with dementia living in care homes: longitudinal course, prevalence and treatment implications. J Am Med Dir Assoc. 2017;18(5):453.e1-453.e6.
doi: 10.1016/j.jamda.2017.01.024